Acquired myeloma-associated Type III hyperlipidaemia treated by nonmyeloablative HLA-identical sibling allogeneic stem cell transplant using a donor with essential thrombocythaemia (ET): evidence of engraftment without manifestation of ET in recipient

Bone Marrow Transplant. 2005 Jun;35(12):1213-4. doi: 10.1038/sj.bmt.1704973.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Female
  • Graft Survival
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Hyperlipoproteinemia Type III / etiology*
  • Male
  • Middle Aged
  • Multiple Myeloma / complications*
  • Siblings
  • Thrombocythemia, Essential*
  • Tissue Donors
  • Transplantation, Homologous